Outsourcing plays a critical role in modern drug development and manufacturing: one that has gained increasing importance in recent years.
The continued rise in demand for complex modalities, such as peptides and oligonucleotides, and increased pressures on time-to-market, have amplified the need for external partnerships and collaboration to ensure the supply of crucial medications to patients.